Found: 7
Select item for more details and to access through your institution.
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00996-x
- By:
- Publication type:
- Article
Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 5, p. 865, doi. 10.1111/bjh.18704
- By:
- Publication type:
- Article
Diffuse large B‐cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 9, p. 1609, doi. 10.1111/imj.15533
- By:
- Publication type:
- Article
Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
- Published in:
- Internal Medicine Journal, 2021, v. 51, n. 12, p. 2119, doi. 10.1111/imj.15503
- By:
- Publication type:
- Article
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 6, p. 667, doi. 10.1111/imj.14859
- By:
- Publication type:
- Article
First report of human babesiosis in Australia.
- Published in:
- Medical Journal of Australia, 2012, v. 196, n. 5, p. 350, doi. 10.5694/mja11.11378
- By:
- Publication type:
- Article
Characteristics and Outcomes of Older Patients With Classical Hodgkin Lymphoma: An Australasian Lymphoma Alliance, and Lymphoma and Related Diseases Registry Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 5, p. 370, doi. 10.1016/j.clml.2023.01.014
- By:
- Publication type:
- Article